|
|
Our pharmaceuticals companies offer medicines that treat many of the world's most serious and widespread diseases. The pharmaceutical segment’s broad portfolio focuses on five therapeutic areas: cardiovascular and metabolic diseases, immunology, infectious diseases, neuroscience and oncology. In 2009, we invested $4.6 billion in pharmaceutical research for new medicines to treat these and many other diseases. It’s all part of our commitment to helping you and the ones you love lead longer, healthier lives.
These companies are organized into three global business units:
Central Nervous System and Internal Medicine
This business unit develops medicines for an array of health problems, including central nervous system disorders, such as schizophrenia and epilepsy; metabolic diseases, such as diabetes; cardiovascular diseases; and infectious diseases.
B.I.O. (Biotechnology, Immunology & Oncology)
This business unit develops traditional and biologic medicines to treat autoimmune disorders, such as rheumatoid arthritis, psoriasis, and Crohn’s disease; a wide range of cancers; and blood disorders, such as anemia.
Virology
This business unit develops medicines for the treatment of infectious diseases, such as HIV/AIDS, hepatitis C and tuberculosis.
Explore the map and view the video to learn more about our pharmaceutical companies around the world. Also see:
Prescription Products
Johnson & Johnson Pharmaceutical Research & Development
|
